Clinical trials recruiting for ANCA Associated Systemic Vasculitis
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| UCAR T-cell | 2 |
| QT-219CX | 1 |
| TI-0032-III injection | 1 |
Self-screener
Recruiting trials
- A Clinical Study of TI-0032-III Injection in Patients With Relapsed and Refractory Autoimmune Diseases
- Allogeneic CD19/BCMA CAR-T for B Cell-Related Autoimmune Disease
- CAR T-cell Therapy Targeting CD19 and BCMA in Patients With B Cell Mediated Autoimmune Disease
- CD19/BCMA UCAR-T for B Cell-Related Autoimmune Disease
Related conditions
Trials recruiting for ANCA Associated Systemic Vasculitis often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for ANCA Associated Systemic Vasculitis trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.